Get started
Author

Johnathan Friedberg

OpenAlex ID: A5081361985
In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells
2014 · Girija Dasmahapatra, Hiral Patel, et al. · Molecular Cancer Therapeutics · 37
Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma
2022 · Fateeha Furqan, Kwang W. Ahn, et al. · British Journal of Haematology · 8
Data from In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells
2023 · Girija Dasmahapatra, Hiral Patel, et al.
Supplementary Methods from In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells
2023 · Girija Dasmahapatra, Hiral Patel, et al.
Supplementary Figures S1 - S8 and Tables S1 - S2 from In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells
2023 · Girija Dasmahapatra, Hiral Patel, et al.
Supplementary Figures S1 - S8 and Tables S1 - S2 from In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells
2023 · Girija Dasmahapatra, Hiral Patel, et al.
Supplementary Methods from In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells
2023 · Girija Dasmahapatra, Hiral Patel, et al.
Data from In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells
2023 · Girija Dasmahapatra, Hiral Patel, et al.
Retraction: In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells
2019 · Girija Dasmahapatra, Hiral Patel, et al. · Molecular Cancer Therapeutics
Works count: 9
Citation count: 45
H-index: 2
I10-index: 1
Year
Topic
Type